The Effects of 8 oz Fresh vs. Commercial Orange Juice on Blood Pressure In Normotensive Males Aged 18-59
Sponsor:
Loma Linda University
Collaborators:
Information provided by (Responsible Party):
Cory Gheen,Loma Linda University
Tracking Information | |||
---|---|---|---|
First Submitted Date ICMJE | September 24, 2018 | ||
First Posted Date ICMJE | October 1, 2018 | ||
Last Update Posted Date | October 1, 2018 | ||
Actual Study Start Date ICMJE | October 2018 | ||
Estimated Primary Completion Date | June 2019 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures ICMJE |
blood pressure[ Time Frame: change from baseline to 4 weeks ] Three readings will be taken each time and average them. If the subject's blood pressure is considered too high or low at any of the visits, they will be dropped from the study and we will suggest to them to see their primary physician. |
||
Original Primary Outcome Measures ICMJE | Same as current | ||
Current Secondary Outcome Measures ICMJE |
|
||
Descriptive Information | |||
Brief Title ICMJE | The Effects of 8 oz Fresh vs. Commercial Orange Juice on Blood Pressure In Normotensive Males Aged 18-59 |
||
Official Title ICMJE | The Effects of 8 oz Fresh vs. Commercial Orange Juice on Blood Pressure In Normotensive Males Aged 18-59 |
||
Brief Summary | The purpose of this graduate student research study is to determine the effects of drinking eight ounces of fresh vs. commercial orange juice on blood pressure in males with normal blood pressure. |
||
Detailed Description | Visit 1 Beginning of the first four weeks: Upon arrival, subjects will be given a consent form to sign. The student investigators will go over the layoutof the research study such as the procedures, and compliance with them. Then, subjects will be asked if they agree with drinking orange juice daily for two months. If they agree, they will be asked to relax for five minutes, and the student investigators will take their blood pressure reading three times using a blood pressure monitor. The subjects will complete the Perceived Stress Scale (PSS) survey before leaving. The subject will drink orange juice for 28 days. • Visits 2, 3, and 4: Subjects will meet with the student investigators at a convenient location. Subjects will be asked to rest for five minutes. Student investigators will then take their blood pressure reading three times using a blood pressure monitor. The subjects will complete the PSS survey before leaving. • Between visit 2 and 3: There is a washout period of approximately eight weeks. • During the first and second set of the 4 -week intervention phase, subjects will visit student investigators to retrieve orange juice samples every 3 or 4 days. | ||
Study Type ICMJE | Interventional | ||
Study Phase | N/A | ||
Study Design ICMJE | Allocation: Randomized Intervention Model: Crossover Assignment Intervention Model Description: Masking: Interventional Masking Description: Primary Purpose: Other |
||
Condition ICMJE | |||
Intervention ICMJE |
|
||
Study Arms |
|
||
Recruitment Information | |||
Recruitment Status ICMJE | Recruiting | ||
Estimated Enrollment ICMJE |
20 | ||
Original Estimated Enrollment ICMJE | Same as current | ||
Estimated Study Completion Date | June 2019 | ||
Estimated Primary Completion Date | June 2019 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria ICMJE | Inclusion Criteria: Healthy 18-59 years old males, willing to keep the same lifestyle, not taking any medications or antioxidant supplements to control blood pressure, and do not drink any types of orange juice within 30 days. Exclusion Criteria: Diabetic, smoke cigarettes, marijuana or electronic cigarettes, drink alcohol more than one a week, allergic to oranges, and diagnosed as hypotensive or hypertensive. | ||
Sex/Gender |
|
||
Ages | 18 Years and older (Adult, Older Adult) | ||
Accepts Healthy Volunteers | No | ||
Listed Location Countries ICMJE | United States | ||
Removed Location Countries | |||
Administrative Information | Has Data Monitoring Committee | ||
U.S. FDA-regulated Product |
Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No |
||
IPD Sharing Statement |
|
||
Responsible Party | Cory Gheen,Loma Linda University | ||
Study Sponsor ICMJE | Loma Linda University | ||
Collaborators ICMJE | |||
Investigators ICMJE |
|
||
PRS Account | Loma Linda University | ||
Verification Date | September 2018 | ||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
请使用微信扫码报名